# Anticoagulant Therapy During Pacemaker Implantation

> **NCT00479362** · PHASE4 · COMPLETED · sponsor: **University of Turku** · enrollment: 447 (actual)

## Conditions studied

- Hemorrhage
- Thrombosis
- Embolism

## Interventions

- **DRUG:** Warfarin
- **DRUG:** Aspirin
- **DEVICE:** Permanent pacemaker
- **DEVICE:** Implantable Cardioverter-defibrillator

## Key facts

- **NCT ID:** NCT00479362
- **Lead sponsor:** University of Turku
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 447 (ACTUAL)
- **Last updated:** 2012-09-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00479362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00479362, "Anticoagulant Therapy During Pacemaker Implantation". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00479362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*